282 completed, 145 recruiting, 128 unknown, 53 terminated. 730 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 730 | Completed 282, Recruiting 145, Unknown 128, Terminated 53, Not yet recruiting 40, Withdrawn 36, Active not recruiting 35, Enrolling by invitation 8, Suspended 3 |
Follow Urologic Neoplasms: new trials by email Literature Review of Urologic Neoplasms trials Research Report on Urologic Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder Cancer AI Uro-Cam - Bladder Cancer | Not applicable | Not yet recruiting | Chinese University of Hong Kong | 60 | 2028-07-01 | 2026-10-28 |
| Evaluating the Safety and Performance of the Eight Medical Hyperthermia System IV 1.0 for HIVEC in NMIBC. Hyperthermic intravesical chemotherapy (HIVEC) - Non-muscle Invasive Bladder Cancer (NMIBC) | Not applicable | Not yet recruiting | Eight Medical International BV | 30 | 2027-01-01 | 2026-08-14 |
| VA Randomized Trial of Surveillance Intervals After Transurethral Resection of High Grade Bladder Tumors Low Intensity Surveillance, High Intensity Surveillance - High-Grade Early-Stage Bladder Cancer | Not applicable | Not yet recruiting | VA Office of Research and Development | 2482 | 2027-01-01 | 2026-02-13 |
| A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors. Signatera Genome ultra-sensitive ctDNA blood test - NSCLC (Advanced Non-small Cell Lung Cancer), NSCLC (Non-small Cell Lung Cancer) | Not applicable | Not yet recruiting | Natera, Inc. | 920 | 2027-01-01 | 2026-10-27 |
| Radical CystEctomy or RaDio-chEMotherapy as Preferred Treatment for invasivE blaDder Cancer Radiochemotherapy, Radical cystectomy - Muscle Invasive Bladder Cancer | Not applicable | Not yet recruiting | Brazilian Clinical Research Institute | 336 | 2026-12-01 | 2026-10-29 |
| Comparing Two Weight Loss Programs for the Prevention of Kidney Cancer Progression Among Patients With Small Renal Masses on Active Surveillance Intermittent Fasting, Continuous Energy Restriction (CER) - Renal Cell Carcinoma (RCC) | Not applicable | Recruiting | Roswell Park Cancer Institute | 20 | 2026-11-01 | 2026-10-16 |
| Role of ERBT Plus Intravesical BCG in Intermediate-Risk or High-Risk NMBC Conventional Transurethral Resection of Bladder Tumour, Transurethral En Bloc Resection of Bladder Tumour - Bladder Cancer | Not applicable | Recruiting | Chinese University of Hong Kong | 732 | 2026-10-19 | 2026-10-27 |
| Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients Hyperthermic Intravesical Chemotherapy (HIVEC) - Non Muscle Invasive Bladder Cancer, Bladder Cancer | Not applicable | Not yet recruiting | AC.TA. S.r.l. | 50 | 2026-10-15 | 2026-05-06 |
| The Role of Definitive Radiotherapy in Non Muscle Invasive Bladder Cancer Definitive radiotherapy, BCG, Concurrent chemotherapy - Non Muscle Invasive Bladder Cancer | Not applicable | Not yet recruiting | Assiut University | 70 | 2026-10-02 | 2026-10-14 |
| Feasibility of Automatic, Laser-based Distance Control in Persons With Superficial Bladder Tumors ATLAS system - NMIBC | Not applicable | Recruiting | Optheras AS | 25 | 2026-10-02 | 2026-10-06 |
| Effect of Non-Clamping and Sutureless Technique on Postoperative Renal Function in Robot-Assisted Partial Nephrectomy Off-Clamp, Sutureless Robot-Assisted Partial Nephrectomy, Conventional Robot-Assisted Partial Nephrectomy With Artery Clamping and Sutured Reconstruction - Renal Neoplasms, Localized Kidney Tumors | Not applicable | Recruiting | Shao Pengfei | 304 | 2026-10-01 | 2026-10-22 |
| QLESP Block for Pain Control in Robotic Partial Nephrectomy ropivacaine (local infiltration), ropivacaine - Renal Cell Carcinoma (Kidney Cancer), Postoperative Pain | Not applicable | Recruiting | Huazhong University of Science and Technology | 120 | 2026-09-22 | 2026-09-25 |
| CAIX-targeted PET/CT in Solid Tumors 68Ga-CAIX - Malignant Solid Tumors, Clear Cell Renal Cell Carcinoma | Not applicable | Recruiting | Zhongnan Hospital | 100 | 2026-09-21 | 2026-10-13 |
| Stereotactic Body RadioTherapy With Continuous Tracking for Primary and Secondary Renal Cancer Stereotactic body radiotherapy (SBRT) - Renal Cancer, Renal Secondary Cancer | Not applicable | Recruiting | IRCCS San Raffaele | 60 | 2026-09-14 | 2026-10-27 |
| Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy Acupuncture, Exercise - Metastatic Bladder Cancer, Peripheral Neuropathy | Not applicable | Recruiting | Dana-Farber Cancer Institute | 20 | 2026-09-03 | 2026-10-26 |
| Patient Reported Outcomes and Different Renal Artery Clamping Techniques During Robot Assisted Kidney Resection Standard clamping strategy, Early declamping strategy - Renal Cell Carcinoma (Kidney Cancer) | Not applicable | Not yet recruiting | Bjarte Almas | 130 | 2026-09-01 | 2026-10-01 |
| REtrieval of Transurethrally Resected Intact En-bloc Vesical Tumors Using a Retrieval Device for Bladder Tumors CURTIS retrieval device - Bladder Cancer, Bladder Cancer TNM Staging Primary Tumor (T) T1 | Not applicable | Not yet recruiting | Ludwig-Maximilians - University of Munich | 75 | 2026-09-01 | 2026-08-17 |
| Transplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial Nephrectomy Donor Radical and Partial Nephrectomy, Kidney Transplantation, Laparoscopic Radical Nephrectomy - Renal Cell Carcinoma | Not applicable | Not yet recruiting | Case Comprehensive Cancer Center | 5 | 2026-09-01 | 2026-08-06 |
| Feasibility of HISA During TURBT for NMIBC HISA - Bladder Cancer, Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy) | Not applicable | Not yet recruiting | CAMC Health System | 40 | 2026-08-15 | 2026-09-14 |
| Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-Shedding Intermediate-Risk NMIBC Active Surveillance, Adjuvant Intravesical Chemotherapy - Bladder Cancer, Non-Muscle-Invasive Bladder Cancer (NMIBC) | Not applicable | Recruiting | Tianjin Medical University Second Hospital | 670 | 2026-08-10 | 2026-10-09 |
Showing 20 of 730. Sign in to see all of them.
Urinary Bladder Neoplasms (360) · Carcinoma, Renal Cell (226) · Kidney Neoplasms (164) · Prostatic Neoplasms (79) · Breast Neoplasms (61) · Non-Muscle Invasive Bladder Neoplasms (50) · Neoplasms (49) · Lung Neoplasms (45) · Melanoma (37) · Colorectal Neoplasms (33) · Colonic Neoplasms (30) · Ovarian Neoplasms (29) · Pancreatic Neoplasms (28) · Sarcoma (27)
Female Urogenital Diseases (730) · Female Urogenital Diseases and Pregnancy Complications (730) · Male Urogenital Diseases (730) · Urogenital Diseases (728) · Neoplasms by Site (727) · Urogenital Neoplasms (724) · Urologic Diseases (721) · Neoplasms (681) · Urinary Bladder Diseases (376) · Kidney Diseases (360) · Neoplasms by Histologic Type (346) · Neoplasms, Glandular and Epithelial (317) · Carcinoma (305) · Adenocarcinoma (231)
Radiosurgery (14) · Standard of Care (12) · Sunitinib (12) · Blood Specimen Collection (10) · Exercise (9) · Cystectomy (8) · Early Intervention, Educational (7) · Magnetic Resonance Spectroscopy (7) · Cystoscopy (6) · Gemcitabine (6) · Practice Guidelines as Topic (6) · Radiotherapy (6) · Surgical Procedures, Operative (6) · Surveys and Questionnaires (6) · Anesthesia, General (5)
Mansoura University (20) · Seoul National University Hospital (12) · RenJi Hospital (10) · Roswell Park Cancer Institute (10) · The First Affiliated Hospital with Nanjing Medical University (10) · UNC Lineberger Comprehensive Cancer Center (10) · Chinese University of Hong Kong (9) · Duke University (8) · Stanford University (8) · University Hospital, Bordeaux (8) · Case Comprehensive Cancer Center (7) · M.D. Anderson Cancer Center (7) · Beth Israel Deaconess Medical Center (6) · City of Hope Medical Center (6) · Jørgen Bjerggaard Jensen (6)
United States (233) · China (85) · France (62) · Egypt (43) · Denmark (32) · South Korea (30) · Canada (27) · Italy (27) · United Kingdom (22) · Turkey (Türkiye) (17) · Netherlands (15) · Germany (13) · Switzerland (13) · Spain (12) · Belgium (9)
Amr A Elsawy (6) · Yair Lotan, MD (3) · Young-Kug Kim, MD, PhD (3) · Ahmed A. Shokeir (2) · Ahmed Elkashef (2) · Ahmed Elshal, MD (2) · Ahmed Mosbah (2) · Ahmed Mosbah, MD (2) · Ali Kaan Yildiz (2) · Andrew Rosenkrantz, MD (2) · Anil Kapoor, MD, FRCSC (2) · Ashgan R Ali, MD (2) · Eugene Lee, MD (2) · Fangjian Zhou, professor (2) · Haitao Niu, PhD (2)
PMID 24373477, PMID 25150172, PMID 33931361, PMID 41673778, PMID 11229684, PMID 11923603, PMID 12136861, PMID 12525530, PMID 12559270, PMID 14532767, PMID 15076282, PMID 15093567, PMID 15199091, PMID 15586136, PMID 15780356, PMID 15814627, PMID 1612951, PMID 16685271, PMID 17804777, PMID 17993339, PMID 18295861, PMID 18794310, PMID 18803341, PMID 18947938, PMID 19222048, PMID 19508716, PMID 19683266, PMID 19690306, PMID 20238325, PMID 20303878, PMID 20429726, PMID 20509796, PMID 20633979, PMID 20689253, PMID 20855414, PMID 20956472, PMID 21126687, PMID 21146917, PMID 21272338, PMID 21354816, PMID 21458150, PMID 21741163, PMID 22050425, PMID 22067707, PMID 22280855, PMID 22444831, PMID 22504933, PMID 22543204, PMID 22658217, PMID 22877502
P30CA043703 (4), P30CA014089 (3), P30CA015704 (3), P30CA016056 (3), P30CA033572 (3), 2017 (2), 2019 (2), 2018 (1), 5UG1CA189824-08 (1), F31CA239330 (1), K01CA255414 (1), K08CA304375 (1), P01CA018029 (1), P01CA229997 (1), P30CA006973 (1)